Skip to content

Awareness, Care & Treatment In Obesity Management

Awareness, Care & Treatment In Obesity Management - An Observation in France

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05690789
Acronym
ACTION-France
Enrollment
1688
Registered
2023-01-19
Start date
2022-09-27
Completion date
2023-03-31
Last updated
2023-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

ACTION France is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor. The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Interventions

OTHERNo treatment given

No treatment given

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

People Living with Obesity 1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol). 2. Male or female, aged above or equal to 18 years at the time of signing informed consent Lives in France 3. Current BMI based on self-reported height and weight of at least 30 kg/m\^2 Health Care Professionals 1. Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol) 2. Male or female, aged greater than or equal to 18 years at the time of signing informed consent. 3. Physician with a license to practice 4. Specialty is not surgeon (including bariatric or plastic surgeon) 5. Practices in France 6. In clinical practice greater than or equal to 2 years 7. Spends at least 70 percent time in direct patient care 8. Has seen at least 100 patients in past month 9. Has seen at least 10 patients in past month needing weight management defined as: a patient with a BMI greater than or equal to 30 kg/m\^2 with or without comorbidities. Employers 1. Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol) 2. Age 18 years old or older 3. works in France 4. Company offers health insurance benefits 5. Responsible for making or influencing decisions about employee benefits plan or health and wellness programs 6. works in a company that has at least 20 employees 7. not affiliated with pharma, MR or advertising firms

Exclusion criteria

People Living with obesity 1. Previous participation in this study. Participation is defined as having given online consent in this study 2. Currently pregnant 3. Participates in intense fitness or body building programs 4. Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months 5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation Health Care Providers 1. Previous participation in this study. Participation is defined as having given informed consent in this study. 2. Unwillingness, inability, or language barriers precluding adequate understanding or cooperation. Employers 1. Previous participation in this study. Participation is defined as having given informed consent in this study. 2. Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.

Design outcomes

Primary

MeasureTime frameDescription
Degree to which healthcare and society is meeting needs of people living with obesityDay 1-day of survey5-point Likert scale 1=strongly disagree to 5=strongly agree
Proportion of PLwO / participants who made serious weight loss effortDay 1-day of surveyPercentage of participants
Response to weight loss discussionsDay 1-day of surveySingle select from defined list
Effective weight loss methodsDay 1-day of surveyMulti-select from defined list
Obesity attitudesDay 1-day of survey5-point Likert scale 1=strongly disagree to 5=strongly agree
Attitudes toward prescription weight loss medication and surgeryDay 1-day of survey5-point Likert scale 1=strongly disagree to 5=strongly agree
Weight loss barriersDay 1-day of surveyMulti-select from defined list
Obesity and weight managementDay 1-day of survey5-point Likert scale 1=strongly disagree to 5=strongly agree
Weight loss motivatorsDay 1-day of surveyMulti-select from defined list

Secondary

MeasureTime frameDescription
Top factors for improving weight loss outcomesDay 1-day of surveyMulti-select from defined list
Types of weight management goalsDay 1-day of surveyMulti-select from defined list
Most helpful information for participants for weight lossDay 1-day of surveyMulti-select from defined list
Most helpful support for weight lossDay 1-day of surveyMulti-select from defined list
Effectiveness of guidelines for treating obesityDay 1-day of survey5-point Likert scale 1=strongly disagree to 5=strongly agree
Ways participants receive information on weight loss managementDay 1-day of surveyMulti-select from defined list
Responsibility for improving health of people living with obesityDay 1-day of surveyMulti-select from defined list

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026